Drugs, healthcare services and medical devices continue to remain the most fundamental need of humans as well as any other living creatures that may have access to them. The larger healthcare industry, which is now estimated to be worth around $300 trillion, serves this basic requirement. Hundreds of healthcare companies have listed their stocks for active trading on the leading stock exchanges across the globe. It allows a convenient channel to short term traders as well as long term investors to take a shot at the performance of such healthcare companies with an aim to generate profits. Among the several healthcare companies whose stocks are listed and actively trading on the stock exchanges, which have been the winners in terms of highest returns? This article provides a list of healthcare stocks that have given the top returns in the year 2020 till date of writing. The list is prepared based on the percentage returns generated by the individual healthcare stocks between the end of the previous and Dec 31, 2020, and the top 10 return generating healthcare stocks are listed below.
Try our new Best Performing Stock Screener:
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.
The following list presents stocks of the companies which belong to the broader Healthcare sector or the stock market index, their corresponding prices as of given date, and the percentage gains realized: 1) miRagen Therapeutics Inc. (MGEN)
Here's a look at the basic details and how the above mentioned stocks fared during the period:
Miragen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing proprietary RNA-targeted therapies with a specific focus on microRNAs and their role in diseases whe ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of miRagen Therapeutics. The Boulder, CO-headquartered company miRagen Therapeutics Inc. (MGEN) is ranked number one among the best performing stocks of Healthcare of 2020. The Health Care sector business falls under the Drug Development industrial sub-sector. Since the start of the year 2020, the stock price of miRagen Therapeutics has changed by 3327.08 percent, which is calculated based on the previous year's closing price of $0.48 per share and year-to-date closing price of $16.45 per share as of writing. The market value of the company as indicated by its market-cap changed from $16.73 million to $64.29 million during the same period. Along with Healthcare, the company is also in the business of Health Care, Drug Development, Diagnostics & Research, Wilshire 5000, among other usual products and services. miRagen Therapeutics continues to be a leading constituent of many major stock market indexes like Wilshire 5000 index, and a few other larger indexes which are part of the stock market.
Novavax, Inc. (Novavax), incorporated on June 18, 1987, is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Novavax. Based on the market-cap change from $105.78 million to $7.1 billion during the given months of the year 2020 and the share price change from $3.98 per share to a price of $111.51 per share as of Dec 31, 2020, Novavax, Inc. (NVAX) was successful in generating YTD returns of 2701.76 percentage. Standing at the number two rank in the top performing list of Healthcare stocks, the Maryland, MD-based Novavax is categorized as the Biotech Biological Products sub-sector business which falls under the larger Health Care sector. It is also a part of few famous stock indexes that are used to track the overall performance of the stock market. They include Wilshire 5000 index, Russell 2000 index, and a few more broader-level indexes that are actively tracked in the market.
Novus Therapeutics, Inc., a pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. Its lead product is (OP-02), a surfactant-based combination drug product ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Novus Therapeutics. During the given months of the year 2020, Novus Therapeutics, Inc. (NVUS) was successful in generating YTD returns of 2555.17 percentage which helped it gain the number three spot in the list of the top performing stocks which generated maximum returns during year 2020 till date. As of December of the previous year, the stock of the Irvine, CA-based Novus Therapeutics closed at a price of $0.58 per share, while it traded at a price of $15.4 per share as of Dec 31, 2020. The company's market cap changed from $7.52 million to $22.12 million during the same period YTD. It ranks as a key constituent of major indexes that include Wilshire 5000 index, and several other broader level multi-cap market indicators.
The company is classified under the Health Care industry sector and further specialized as a Healthcare sector business.
Titan Pharmaceuticals, Inc. (Titan), incorporated on February 7, 1992, is a specialty pharmaceutical company. The Company is engaged in developing therapeutics for the treatment of medical disorders. The Companys segment ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Titan Pharma. The California, CA-based Health Care sector company Titan Pharmaceuticals, Inc. (TTNP) holds the number four spot among the best performing stocks of the Healthcare sector. Classified as the Biotech Biological Products business, the stock price of Titan Pharma ended the previous year at a price of $0.19 per share while it reached the level of $3.29 apiece as of Dec 31, 2020 translating to a percentage change in stock price of 1631.58%. As of writing, the company's market-cap value stands at $21.88 million. Few leading stock market index includes Titan Pharma in their constituent list. They include Wilshire 5000 index, and a few other larger indexes which are part of the stock market.
Vaxart, Inc., a clinical-stage company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus. It is also developing therapeutic immune-oncology vaccines ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Vaxart. Rank number five in the coveted list is held by Vaxart, Inc. (VXRT) for being among the top performing stocks of 2020. Headquartered in USA, the Health Care sector company is categorized under the industrial sub-sector of Healthcare. Since the start of the year 2020, stock of Vaxart has so far gained 1531.43 percentage, based on the previous year's closing price of $0.35 per share and year-to-date price of $5.71 per share. During the same period, the market capitalization of the company changed from $17.09 million to $583.58 million. The stock of Vaxart continues to be a major constituent of many leading stock indexes which include Wilshire 5000 index, Russell 2000 index, and several other broader level multi-cap market indicators.
Hancock Jaffe Laboratories
Hancock Jaffe Laboratories, Inc., a development stage medical device company, develops and sells biological tissue solutions to treat patients with coronary, vascular, end stage renal, and peripheral arterial d ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Hancock Jaffe Laboratories. At number six in the list of top stocks stands Hancock Jaffe Laboratories, Inc. (HJLI), which saw a change in its stock price from the level of $0.55 apiece during previous year December end to the price of $8.65 per share as of Dec 31, 2020. It translates to a change of 1472.73 percentage. The Irvine, CA-headquartered Health Care sector company also saw its market value change from $9.86 million to $19.33 million.
Biocept, Inc., incorporated on June 28, 2013, is an early commercial-stage molecular oncology diagnostics company. The Company develops and commercializes circulating tumor cell (CTC) and circulating tumor deoxyribonucleic acid (ctDNA), ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Biocept. Biocept, Inc. (BIOC) has moved by 1431.03 percentage over the given period of 2020-YTD, helping it gain a place at number seven among the top performing stocks. The Health Care sector company managed to achieve the feat as its stock price changed from $0.29 apiece to the price of $4.44 per share between the end of December of the previous year and Dec 31, 2020. The smart run of the California, CA-based Medical Specialities sector company lead to a handsome gain in its marketcap which changed from $6.58 million to $59.48 million over the same duration. Biocept is a key member of many popular stock market indexes. They include Wilshire 5000 index, and several other broader level multi-cap market indicators.
Trillium Therapeutics Inc., a clinical-stage immuno-oncology company, develops therapies for the treatment of cancer. The company's lead program is TTI-621, a SIRPaFc fusion protein that acts a soluble decoy receptor preventing CD47 from delivering its inhibitory signal, which is in Phase I clinical trial for advanced hematologic malignancies, and solid ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Trillium Therapeutics. The Canada-based Trillium Therapeutics Inc. (TRIL) belongs to the Health Care sector and is categorized as a Major Pharmaceuticals company. The stock of Trillium Therapeutics ended the previous year at a price of $1.03 per share. As of Dec 31, 2020, the stock price has reached $14.71 apiece, which indicates a change of 1328.16 percent making the company rank among the top performing stocks of the Healthcare for the year 2020 till date. At the end of the last year, company's market capitalization stood at $28.62 million. It has now changed to $1.47 billion as of writing.
ImmunoCellular Therapeutics, Ltd., incorporated on March 20, 1987, is a clinical-stage biotechnology company. The Company is developing immune-based therapies for the treatment of cancers. The Companys cancer immunotherapies target cancer ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of ImmunoCellular Therapeutics. ImmunoCellular Therapeutics (IMUC) generated percentage returns of 1266.67 percent during the 2020 year-to-date. Its returns are based on the share price which moved from $0.03 per share from the previous year-end to the price of $0.41 per share as of Dec 31, 2020. The company's value, as indicated by the market-cap figure, changed from $1.43 million to $1.19 million during the same period. The company is categorized as a Health Care speciality business with further classification in the Major Pharmaceuticals sub-category. Based in California, CA, the YTD performance of the Healthcare sector also fared better than that of the returns generated by some of the closley tracked stock market indexes.
Genprex, Inc., a clinical-stage gene therapy biotechnology company, develops immunogene therapy products for treating cancer. Its lead drug candidate is Oncoprex, which is in Phase II clinical trials for the tr ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Genprex. The number ten spot in the list of top performing stocks of the Healthcare sector is taken by Genprex, Inc. (GNPX). The company's stock price changed from $0.32 per share at the end of December of the previous year to the price of $4.15 per share as of writing. Overall, the stock managed to realized price change of 1196.88 percent during the given time period. The corresponding change in the market capitalization value of the Austin, TX-based Health Care sector company was from $6.16 million to $178.67 million. Being ranked in the top 10 best performing stocks of the Healthcare sector, the company also succeeded in outperforming the returns generated by some of the popular stock market indexes. They include the Russell 2000 index, and a handful of other multi-capitalization indexes.This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.